홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Bromomethylcyclopropane → 2,4-Dioxo-1,5-bis-(cyclopropylmethyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine

HRID 987686
인쇄

반응식

HRID 987686 반응식
[O:1]=[C:2]1[NH:8][C:7]2[CH:9]=[CH:10][CH:11]=[CH:12][C:6]=2[NH:5][C:4](=[O:13])[CH2:3]1.Br[CH2:15][CH:16]1[CH2:18][CH2:17]1>>[O:13]=[C:4]1[N:5]([CH2:15][CH:16]2[CH2:18][CH2:17]2)[C:6]2[CH:12]=[CH:11][CH:10]=[CH:9][C:7]=2[N:8]([CH2:15][CH:16]2[CH2:18][CH2:17]2)[C:2](=[O:1])[CH2:3]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 81503BromomethylcyclopropaneHCID 2835341H-1,5-Benzodiazepine-2,4(3H,5H)-dione

생성물 1

HCID 223124822,4-Dioxo-1,5-bis-(cyclopropylmethyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine

실험 절차

2,4-Dioxo-1,5-bis-(cyclopropylmethyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine was prepared following General Procedure 8-M using the product from Example 8-P, Step A and (bromomethyl)cyclopropane (Lancaster). Purification was by flash chromatography eluting with EtOAc/hexanes (3:7 gradient to straight EtOAc), then recrystalization from EtOAc/hexanes.

후처리

  1. customPurification
  2. washeluting with EtOAc/hexanes (3:7 gradient to straight EtOAc)
  3. customrecrystalization from EtOAc/hexanes
이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트

출처 및 근거

ORD 기록
ord-dfd97be58ee5418db74edaefc2a7ecc7
출처 데이터셋
uspto-grants-2003_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06632811B2

반응 노트